Drug Type AAV based gene therapy |
Synonyms AAV-miR-ATXN2(AviadoBio), AVB205 |
Target |
Action modulators |
Mechanism ATXN2 gene modulators |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Amyotrophic Lateral Sclerosis | Preclinical | United Kingdom | 22 Sep 2024 |





